Bertol BC, Bales ES, Calhoun JD, Mayberry A, et al. Lenvatinib plus Anti-PD-1 Combination Therapy for Advanced Cancers: Defining Mechanisms of Resistance in an Inducible Transgenic Model of Thyroid Cancer. Thyroid 2021 Oct 12. doi: 10.1089/thy.2021.0371.
PMID: 34641722